Experiment 903206

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

GINKGOLIDE B

Details

PropertyValue
Pharmacology
LYSOPHOSPHOLIPASE INHIBITION
Administration routeIP
OrganismEmpty organism
CitationBIRKLE,DL: KURIAN,P: BRAQUET,P: BAZAN,NG:. (1988). PLATELET-ACTIVATING FACTOR ANTAGONIST BN52021 DECREASES ACCUMULATION OF FREE POLYUNSATURATED FATTY ACID IN MOUSE BRAIN DURING ISCHEMIA AND ELECTROCONVULSIVE SHOCK.. 51(6)
Amount utilized
Compound isolated
DiseaseVS.INJURY-INDUCED ACTIVATION OF THE ENZYME ACTIVITY.
Dose amount10.0 MG
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE